26.70.Z - Manufacture of optical instruments, magnetic and optical information carriers, and photographic equipment
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,2 | 0,1 | -13,1 |
EBITDA | 0,2 | 0,2 | 0,2 | -13,1 |
Short time liabilities | 0,1 | 0,1 | 0,1 | 17,1 |
Equity capital | 0,4 | 0,6 | 0,6 | 0,1 |
Operating profit (EBIT) | 0,2 | 0,2 | 0,1 | -15,4 |
Assets | 0,5 | 0,7 | 0,7 | 1,4 |
Net profit (loss) | 0,2 | 0,1 | 0,1 | -12,4 |
Cash | 0,2 | 0,2 | 0,1 | -41,4 |
Net income from sale | 1,1 | 1,4 | 1,5 | 13,2 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 9,9 |
Working assets | 0,5 | 0,5 | 0,5 | 8,6 |
Depreciation | 0 | 0 | 0 | -2,7 |
% | % | % | p.p. | |
Profitability of capital | 44 | 25 | 21,9 | -3,1 |
Equity capital to total assets | 82,4 | 86,1 | 85 | -1,1 |
Gross profit margin | 16,9 | 11,6 | 8,9 | -2,7 |
EBITDA Margin | 18,6 | 14 | 10,8 | -3,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 24 | 23 | 24 | 1 |
Current financial liquidity indicator | 6.461851119995117 | 5.36963415145874 | 4.977443695068359 | -0,4 |
Net dept to EBITDA | -1.0584572553634644 | -0.8742803931236267 | -0.6101478338241577 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane